In the presence of the antibiotic tunicamycin (TM), glycosylation of herpes simplex virus glycoproteins is inhibited and non-glycosylated polypeptides analogous to the glycoproteins are synthesized (Pizer et al., J. Virol. 34:142-153, 1980 We have reported that the antibiotic tunicamycin (TM) blocks the synthesis of herpes simplex virus (HSV) glycoproteins and the production of infectious progeny (32). Similar results with TM have been observed previously with enveloped RNA viruses (8, 21, 38, 45, 47) . Investigations of viral glycoprotein maturation have shown that glycosylation is not an obligatory requirement for the insertion of polypeptide chains into membranes (11-13, 35, 46), and that, depending on the virus strain and temperature of infection, virions may be produced (13, 22, 29) . These studies, coupled with the report by Damsky et al. (7) describing the continued appearance of membrane proteins on the surface of TM-treated BHK cells, prompted us to reinvestigate the effect of TM on HSV infection. We were concerned with the possibility that TM was not blocking virus maturation, but that virions lacking the carbohydrate portion of the glycoproteins were being released from the cells as noninfectious progeny. This situation has been reported by Sarmiento et al. for a temperaturesensitive (ts) mutant of HSV altered in glycoprotein B (gB), which attaches to cells but fails to penetrate (37). Also having bearing on this question is a recent paper by Katz et al., which shows a single electron microscope picture of a TM-treated cell with virions indistinguishable from those seen in a control cell (18) . However, in spite of careful examination of the data it was difficult to determine whether the virus in the TM-treated sample was intracellular or extracellular in nature.
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To evaluate the possibility that in TM-treated cells noninfectious virions are being produced which contain the non-glycosylated analogs of the glycoproteins, we investigated viral protein and DNA synthesis and examined infected cells for intracellular virus by electron microscopy. The appearance of viral polypeptides in cell extracts, membranes, and virus preparations was followed by means of a specific antiserum against viral membranes.
From our experiments we have drawn the following conclusions: (i) and cytoplasm of TM-treated cells, whereas unenveloped virions are observed in the cytoplasm and a small number of enveloped virions are observed on the cell surface; (iii) the nonglycosylated analogs of the viral glycoproteins are not inserted into the surface membrane of the cell, nor do they become associated with virion-like structures seen in the cytoplasm in sufficient quantities to be detected by our methods; (iv) viral glycoproteins present on the surface of infected cells early after infection or when de novo protein synthesis is inhibited are placed on the cell by the infecting virus; and (v) the glycoproteins and their non-glycosylated analogs appears to be synthesized early after infection with gA, gB, and gD, preceding gC. It has been generally accepted by investigators studying the glycoproteins of HSV that the four major species in the virus, gA, gB, gC, and gD, have corresponding precursor forms in the cell: pgA, pgB, pgC, and pgD (10, 17, 40, 43) . The labeling conditions we use give mainly the precursors, and pgA/pgB appear after electrophoresis as one band migrating close to pgC. By using conditions of infection under which pgC is not produced, it has been possible to identify a single non-glycosylated analog to pgA/pgB and to confirm that an 85,000-dalton (85K) polypeptide is the non-glycosylated analog to pgC.
MATERIALS AND METHODS
Conditions for infection. HSV type 1 (strain HF) was used in this study with BHK-C13 cells as the host. Because the procedures for obtaining virus, growing cells, and performing the infection have previously been described in detail (32, 44) , only a brief description of the experimental conditions will be given below. BHK-13 cells at approximately 75% confluence were infected at a multiplicity of 50 PFU/cell. After 90 min of adsorption the virus was removed and the cultures were overlaid with minimal Eagle medium supplemented with 1% fetal bovine serum and 100 ,um arginine. TM at 2 ,ug/ml was added at this time to the antibiotic-treated cultures. Cycloheximide (CH) was added to the cell cultures at a final concentration of 200 ,ug/ml 30 (32, 44) . The specific information on the quantity of isotope used and the periods of time that the infected cells were exposed to the radioactive compounds has been presented in the text describing each experiment or in the legends to the figures.
Surface labeling of cells with Na 125I was carried out using the procedure described by Markwell and Fox (26) . The infected cells in 60-mm petri plates were prepared for labeling by removing the culture medium, washing with phosphate-buffered saline, and overlaying each plate with 3 ml of phosphate-buffered saline containing 5 mM glucose and 500 pRCi of Na 1251 (New England Nuclear Corp.). The iodinating compound (lodogen-Pierce Chemical Co., Rockford, Ill.) was coated onto cover slips (100 p.g/cm2) and floated on top of the cells for 10 min at 25°C. The cover slips and the radioactive phosphate-buffered saline were then removed and the cells were thoroughly washed with a phosphate-buffered 7.5% solution of Nal.
Fractionating procedures. Cell extracts were prepared by treating cells with 0.6 ml of lysing buffer containing 50 mM NaCl, 20 mM Tris-hydrochloride (pH 7.5), 0.5% Nonidet P-40, and 0.5% sodium deoxycholate. Nuclei were removed by centrifugation at 10,000 x g, and the supernatant fluids were stored at -200C.
Antiserum against viral envelopes (anti-env serum) was used to precipitate glycoproteins by the Staphylococcus (Staph A)-assisted precipitation procedure (2, 10, 32). A two-step procedure was used in which the radioactive cell extracts were pretreated with nonimmune sheep serum and Staph A immune adsorbant (32) . The Staph A immune adsorbant was removed by centrifugation, and anti-env serum was added to the supernatant fluids. Subsequently, additional Staph A was added, and the antigen-antibody complexes that adhere to the Staph A were thoroughly washed with 50 mM Tris buffer (pH 7.5), containing 1% Nonidet P-40, 0.5% deoxycholate, and 150 mM NaCl, before being dissociated with electrophoresis buffer containing 3% sodium dodecyl sulfate and 2% mercaptoethanol. Dissociation was at 100°C for 3 min, and the Staph A was removed by centrifugation. Polyacrylamide gel analyses of solubilized immune precipitates, cell extracts, or purified virus were carried out by the method described earlier, using a 12.5% gel crosslinked with N,N'-diallyltartardiamide (32) . Viral DNA labeled with [3H]TdR was separated from cellular DNA by equilibrium sedimentation in CsCl gradients (44) , and cytoplasmic virions were purified by sedimentation on Dextran gradients as described by Spear and Roizman (42) . Extracellular virus was obtained from the culture medium by sedimentation at 120,000 x g for 2 h. The methods for preparing cells for electron microscopy have been published along with detailed electron microscopic analyses of HSV-infected and TM-treated BHK cells (7, 33 (Fig. 1A) and 260,000 cpm for the TM-treated extract (Fig. 1B) 30 min at 5 h postinfection, and cytoplasmic extracts were prepared. After electrophoresis, the gel was fluorographed, and the radioautograph was subsequently scanned with a densitometer. Control cell extract is shown in (A); TM-treated extract is shown in (B). The numbers above the peaks are those used by Spear and Roizman (42) 
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The incorporation of tritiated TdR into DNA was not affected by TM. When infected cells were labeled with [3H]TdR (100 ,uCi/ml) from 4 to 6 h after infection, approximately 2 x 105 cpm of thymidine per 106 cells was incorporated into the total DNA from both the TM-treated and the control cultures. In both cases, sedimentation in CsCl gradients demonstrated that approximately 50% of the DNA synthesized in the 2-h period was viral (data not shown). To find out whether the DNA was contained in cytoplasmic viruslike structures, we prepared cytoplasmic extracts 18 h after infection from [3H]TdR-labeled cells. The [3H]TdR was added to the cultures 90 min after infection at a concentration of 100 ,Ci/ ml, and extracts were fractionated on 11 to 30% Dextran gradients designed for virus purification. For both the control and the TM-treated culture a peak of radioactive DNA was found at the position for virus, but the amount of radioactivity was reduced by 60% in the extract from TM-treated cells (Fig. 2) .
Electron microscopic examination of infected cels. Examination of thin sections of HSVinfected cells in the electron microscope showed differences between the TM-treated culture and controls. Several sections from 13 cells prepared from the TM-treated culture and 8 cells from the control were used for this study. By 12 h after infection, enveloped virus was readily found both inside and on the surface of the control cells (Fig. 3A) . In TM-treated cells (Fig. 3B ) nucleocapsids were abundant in the nucleus, and also were unexpectedly found in the cytoplasm, but extracellular virus was difficult to find. Higher magnification showed that 75% of the control cells contained enveloped virions in the cytoplasm (Fig. 3C ). In contrast, all the TMtreated cells had naked capsids in the cytoplasm (Fig. 3D) , and close examination showed that half the cells had a very low number of enveloped virions inside and outside the cell ( 3 . Electron micrographs of thin sections of BIIK cells after HSV infection. Cultures were fixed and sections were prepared 12 h after infection. A and B were photographed at a magnification of x 19,000, using the procedures described in reference 22. C, D, and E were taken at a magnification of x42,000, using the procedure described in reference 2. Control cultures were used for A and C, and TM-treated cultures were used for B, D, and E. Vi, Enveloped virus; Nc, nuclear capsid of virus. The presence of glycoproteins on the surface of the TM-treated cell 6 h after infection is consistent with an incomplete block in glycosylation. It is also consistent with incomplete removal of adsorbed virus or the infecting virus, leaving envelope proteins on the cell surface as they penetrate the cell. The latter interpretation is supported by immunological data that indicate that viral antigens are present on cells early in infection (30, 39) , and by the results of Para et al., who showed the transfer of the immunoglobulin G receptor (gE) from purified virions to the cell surface (31) . To provide information on the origin of the surface glycoproteins found at 6 h in the TM-treated cells, the surface labeling was repeated under conditions in which de novo protein synthesis was inhibited with CH and in which labeling was carried out soon after virus adsorption (90 min). The CH-treated sample appeared identical (Fig. 7, lane B) Immune precipitation of viral glycoproteins from infected cells and virus preparations. Samples of cellular extracts and fractions containing viruses were solubilized with a mixture of buffered detergents (0.5% Nonidet P-40, 0.5% deoxycholate, 150 mM NaCl, 50 mM Tris-chloride, pH 7.5) and subjected to the Staph A-assisted immune precipitation procedure. The washed immune precipitates were electrophoresed, and the dried gel was fluorographed. Approximately the same amount of radioactivity was used for immunoprecipitation of the TM-treated and control samples. For the cytoplasmic extracts (lanes A and D) 15 x 105 cpm was treated with anti-env serum, and for the extracellular virus fractions (lanes B and E) 5 x 105 cpm was used. For the virus fractions from the gradients, 5 x 105 and 1.5 x 105 cpm were used from the control cell extract and the TM-treated cell extract, respectively. The radioautogram has been exposed for different periods of time to detect the weaker bands in the samples from the TM-treated cells. The radioautogram was exposed for 3 days with XRS fast film to detect the bands in the control lanes A, B, and C. Thirty days of exposure was used with slow SRP film to detect the bands shown in lanes D, E, and F. cells labeled immediately after adsorption (Fig.  7, lane A) and the TM-treated extract labeled 6 h after infection (Fig. 7, lane D) . Pretreating cells with TM for 4 h before infection gave the same pattern (data not shown). The control cell extract, labeled 6 h after infection (Fig. 7, lane C (20 ,ul) DNA and that gA, gB, and gD are synthesized before gC.
As an independent check on these results, we investigated glycoprotein synthesis after infection of cells with a DNA-ts mutant blocked early in the infectious cycle. The radioautograph (Fig. 9) shows the immune precipitates obtained from cells infected at 34 and 39°C. The data obtained with the ts mutant HSV(KOS)B2
shows that pgA/pgB (120K) and pgD (52K), but not pgC (110K), were synthesized at 39°C. Comparison of the control and TM-treated cell extracts shows that non-glycosylated analogs to gD and gA/gB are found with molecular weights of 50K and 105K, respectively. The non-glycosylated analog to gC (85K) and the normal precursor to gC, pgC (110K) (32) , are only synthesized at the premissive temperature. the radioactivity present showed that pgA/pgB (120K) contained 900 cpm and pgD (52K) contained 1,500 cpm above background. The nonglycosylated analogs to gA, gB, and gD were found in the cultures treated with both TM and CH (Fig. 8, lane D) . These bands at 50K and 105K both contained 400 cpm. In neither culture was the precursor to gC, pgC, detected on the radioautograph. In the extracts from cultures treated with phosphonoacetic acid (Fig. 8, lanes  E and F) , the quantity of glycoprotein and the corresponding non-glycosylated polypeptides was reduced as compared with the extracts from cells making viral DNA (Fig. 8, lanes A and B) , but bands were found on the gel corresponding to the precursors for all the glycoproteins, including gC. These results indicate that glycoprotein synthesis starts before the synthesis of viral (9, 25) . The straightforward interpretation of these data, that mature glycoproteins are required for nucleocapsid movement into the cytoplasm, is clearly different from the interpretation we draw from our experiment. In discussing the results with cytochalasin B, Dix and Courtney pointed out that the antibiotic alters several aspects of cell structure and transport and that these effects could restrict nucleocapsid movement rather than the absence of glycoproteins (9) .
We found very few enveloped virions in TMtreated cells, and it appeared that the particles we saw did not contain detectable amounts of the non-glycosylated polypeptides related to the viral glycoproteins. We do not know whether these virus-like particles utilize cellular glycoproteins in their assembly, but it appears that under our conditions of infection, HSV fails to insert non-glycosylated forms of glycoproteins into membranes. The few nucleocapsids which can be observed may be budding through those patches of membrane which have been modified by the input virus, or they may be using cellular glycoproteins for assembly (23) . The virions on the surface could be partially uncoated virions remaining from the infecting virus.
In many respects the synthesis and maturation of HSV glycoproteins appear to follow the same biochemical sequence reported for other glycoproteins. Together with or soon after polypeptide synthesis, carbohydrate residues are added to the polypeptide (10, 17, 40) . Subsequently, the glycosylated precursors undergo maturation by altering the structure of the carbohydrate side chains as the glycoproteins migrate through the cell to the surface membranes (10, 17, 19, 40, 41) . Our iodination studies of intact cell surfaces indicate that viral glycoproteins or non-glycosylated analogs do not reach the plasma membrane of TM-treated cells. The antigen present on these cells at 6 h after infection must be residual material introduced by the infecting virus. As Because the non-glycosylated analogs of the viral glycoproteins do not follow the normal maturation sequence which leads to their release from the cell as virus or membrane components, our earlier observation that these polypeptides labeled during a pulse lose radioactivity during a chase can best be interpreted as intracellular degradation. The proteolytic degradation of the non-glycosylated polypeptides appears to maintain a low steady-state intracellular level of these components which might limit their ability to be inserted into membranes or participate in viral maturation. Provided conditions could be found in which degradation of these polypeptides was minimized, a direct test of their role in membrane assembly and intracellular movement of virus could be carried out. Techniques are now available to produce mutants with alterations in specific regions of the genome (2, 36) and to select for mutants defective in glycoprotein synthesis (14, 24) . By combining these methods, it should be possible to obtain mutants deficient in specific glycoprotein and test whether individual glycoproteins are required for virus maturation.
Whereas ts mutants with blocks in the individual glycoproteins would be useful in studying the stages in viral maturation, the single experiment described in this paper with the early mutant HSV(KOS)B2 has provided useful information on the kinetics of glycoprotein synthesis and relationships between polypeptides precipitated J. VIROL.
by anti-env serum. The results with the mutant are in agreement with our data obtained with CH and the kinetic studies of Cohen et al., which show that the synthesis of gC starts later in the infectious cycle than that of the other glycoproteins (4) . These results, together with the mutant studies of Marsden et al., place the glycoproteins among the "early class" of viral proteins (27, 28) . Because mutants in the same complementation group as HSV(KOS)B2 show somewhat different phenotypes (34, 43) , it might be possible through the use of other members of this group to separate the synthesis of gA, gB, and gD from each other and study their regulation in detail.
Blocking gC synthesis by infecting with HSV(KOS)B2 at the nonpermissive temperature has provided a clearer picture of the relationships between the polypeptides in the 100,000 to 130,000 molecular weight range. It appears that a non-glycosylated polypeptide of 105K made early in infection corresponds to the 120K precursor to gA/gB. Under permissive conditions, the 85K non-glycosylated polypeptide and the 110K polypeptide (pgC) are synthesized during a 30-min pulse. The relationship between the 85K, the 110K (pC), and the 130K (gC) polypeptides has been previously demonstrated on the basis of tryptic peptide mapping (3, 32) . The absence of both the 85K and 110K polypeptides in Fig. 9 , lanes E and F, confirms the connection between these molecules. It appears that the non-glycosylated polypeptide analogs and the corresponding glycoproteins are synthesized at the same time after infection. We have not detected additional polypeptides in the immune precipitates that might represent novel glycoprotein precursor made early, and the increase in glycoprotein synthesis observed after DNA synthesis has started is characteristic of many structural proteins destined to become part of the virion (16) . In the original paper describing the "cascade regulation" of herpes protein production it was pointed out that some proteins that are placed in the -y class because their rates of synthesis increase after viral DNA synthesis was initiated were synthesized early after infection (16) . 
